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Abstract. Magnetic nanoparticles have many applications in biomedicine and 
other technical areas. Despite their huge economic impact, there are no standard-
ised procedures available to measure their basic magnetic properties. The Inter-
national Organization for Standardization is working on a series of documents on 
the definition of characteristics of magnetic nanomaterials. We review previous 
and ongoing European research projects on characteristics of magnetic nanopar-
ticles and present results of an online survey among European researchers.   
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1 Introduction 
Liquid suspensions of magnetic nanoparticles (MNPs) are used in many technical areas 
like loudspeakers, mobile phones, vacuum sealings, metal separation and water reme-
diation. In the biomedical applications, MNPs play a very important role in in-vitro 
diagnostics for the separation of cells, bacteria, viruses, protein, nucleic acids and other 
compartments from blood and body liquids. MNPs are used as contrast agents in Mag-
netic Resonance Imaging, as well as tracers in Magnetic Particle Imaging and sentinel 
lymph node detection as well as in MNP based therapies, where they act as heating 
agents in magnetic field hyperthermia or as drug carriers in magnetic drug targeting and 
magnetic gene therapies [1]. The economic impact of MNP based biomedical products 
of European companies alone amounts so far to more than 2 billion € per year [2]. The 
largest part of this economic impact is generated by in-vitro diagnostics applications. 
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Another large application field is the use of nanostructured iron oxide in pigments for 
cosmetics, structural engineering, and many other purposes. The annual production of 
those pigments alone in the European Union is more than 100,000 tons per year [3]. 
Obviously, this creates a demand for international standards on the main characteristics 
of MNPs and the respective measurement procedures.  
The International Organization for Standardization (ISO) currently prepares docu-
ment standards on magnetic nanomaterials to provide harmonised definitions for com-
mercial trade, application development, regulation and science in the MNP sector. Cur-
rent activities focus on magnetic nanosuspensions (ISO 19807-1) [4] and magnetic 
beads for DNA extraction (ISO 19807-2) [5].  
In a new field such as nanotechnology, the foremost interest is the definition of terms 
and characteristics. These terms can then be used by MNP manufacturers for labelling 
their products and designing technical data sheets, or by scientists exchanging infor-
mation on MNPs. While the definitions for chemical composition and mechanical fluid 
properties could be taken from existing standard documents, many of the magnetic 
properties of MNP suspensions needed a new definition.  
The selection of important MNP characteristics should be based on reviews of the 
scientific work on MNPs and of economically relevant MNP based applications. Out-
standing in this field have been two pre-normative European projects: The EU FP7 
project NanoMag, devoted to metrological groundwork on MNP standardisation and 
the EU COST Action RADIOMAG, that dealt with the standardisation of the measure-
ment of MNP hyperthermia performance. Both projects will be briefly summarized in 
this paper. Furthermore, this paper is a result of the co-normative EURAMET project 
MagNaStand, which is supporting the ISO standardisation of MNP. In the framework 
of MagNaStand, we have evaluated the European CORDIS database for previous and 
running EU-projects concerned with MNP. In addition to the pure database work, we 
have also performed a survey of researchers involved with MNPs.  
2 Pre- and co-normative EU projects on magnetic nanoparticles 
2.1 The pre-normative EU NanoMag project 
The NanoMag project was funded by the EU FP7 research program in the years 2013 
– 2017 and had a budget of about 11 M€. The NanoMag project objectives were to 
standardise and harmonise ways to measure and analyse the data for MNP systems. 
NanoMag brought together leading experts in: synthesis of magnetic single- and multi-
core nanoparticles, characterisation of magnetic nanoparticles, and national metrology 
institutes. The project defined standard measurements and techniques which are neces-
sary for defining a magnetic nanostructure and quality control [6]. NanoMag was fo-
cused on biomedical applications, for instance bio-sensing (detection of different bi-
omarkers), contrast substance in tomography methods (Magnetic Resonance Imaging 
and Magnetic Particle Imaging) and magnetic hyperthermia (for cancer therapy).  
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Fig. 1. Important parameters of liquid MNP suspensions that can be standardised. 
Initially, NanoMag was designed as a pre-normative project for the preparation of 
measurement standards. When the International Organization for Standardization 
started a normative activity for material properties of MNP suspensions, NanoMag 
members entered the ISO committee TC 229 “Nanotechnologies” as technical experts 
and made substantial contributions to ongoing ISO standardization work in the field of 
MNP systems.  
The knowledge of the NanoMag experts has been summarized in four electronic-
learning modules that can be accessed via the internet [7].  
To support MNP standardization the NanoMag project has: 
• developed a clearer nomenclature to describe the structure and magnetic properties 
of MNPs and MNP ensembles (see Fig. 1);  
• performed surveys of measurement methods for MNPs and their pros and cons, clas-
sification of these methods including also classification of different types of MNPs 
(single-core, multicore, nanoflowers); 
• used Monte-Carlo simulations to explain the experimental results, which have led to 
improved modelling of MNP magnetic properties, especially the dynamic magnetic 
behaviour; and 
• performed initial round robin measurements (using the same analysis methods on 
the same MNP samples but in different laboratories utilizing the developed standard 
operating procedures (SOPs)) using different types of MNP systems. 
A standardization roadmap developed during the NanoMag project forecasted the de-
velopment of measurement standards for MNP to start in the year 2021. Many results 
of the NanoMag project were summarized in a review paper in [8].  
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2.2 EU Transdomain COST Action RADIOMAG 
The EU COST Action RADIOMAG was a network of over 140 scientists in the field 
of tumour therapy and it was dedicated to research on multifunctional nanoparticles for 
Magnetic Field Hyperthermia and Indirect Radiation Therapy. The RADIOMAG pro-
ject duration was from 2014 – 2018. An important task of RADIOMAG was the har-
monisation and standardisation of the assessment of heat generation by MNP in an al-
ternating magnetic field, since this is the basic principle in Magnetic Field Hyperther-
mia [9].   
Magnetic Field Hyperthermia, especially in combination with radiotherapy, has been 
demonstrated as an effective tool to slow down or stop tumour growth and to support 
anti-cancer therapy in difficult tumour cases like glioblastoma. Pilot studies in humans 
are underway in a number of clinics in Europe. In April 2019 a new magnetic field 
hyperthermia treatment centre for brain tumours has been opened at the Independent 
Public Clinical Hospital No. 4 (SPSK 4) in Lublin, Poland [10]. 
These continuous developments have also created a niche market for several small 
and medium-sized enterprises for manufacturing magnetic field hyperthermia test de-
vices. These devices are mainly used by academics testing in-vitro and ex-vivo the ef-
ficiency of MNP suspensions to deliver heat. The relevant physical quantity is the Spe-
cific Loss Power (SLP). For calorimetric determinations, the SLP is deduced from time 
vs. temperature curves T(t), measured with the SLP test device. 
The RADIOMAG activities concerning the standardized characterization of MNP 
for magnetic field hyperthermia focused on SLP measurements: 
1. Survey amongst RADIOMAG members on available SLP test devices/setups and 
their field/frequency combinations; 
2. Development of a standard operating procedure for the calorimetric SLP determina-
tion, i.e. from T(t) measurements; 
3. A comparative SLP determination on water-based ferrofluids between 21 participat-
ing laboratories (SLP ring test) and evaluation of SLP calculation methods; 
4. Study of the field dependence, i.e. SLP(H); and 
5. Design of a possible calibration sample for SLP test devices. 
The results showed that a large majority of groups determine the SLP from calorimetric 
measurements with non-adiabatic setups, also commercially available on the market. 
In contrast, only a few producers exist for non-calorimetric devices using AC hysteresis 
and a single laboratory used a “home-made” nearly adiabatic setup. 
The RADIOMAG work demonstrated that there are no common procedures availa-
ble for carrying out T(t) measurements in magnetic field hyperthermia setups. Typi-
cally, different laboratories use their own individual best-practice protocols, or follow 
instructions given in the SLP test device manual, in case of commercial setups. 
RADIOMAG has therefore developed a SOP for measurements, including a question-
naire for instrument specific parameters. 
Furthermore, RADIOMAG performed a ring test on the determination of SLP val-
ues, where the same MNP formulation was investigated by 21 different laboratories. 
The results showed a significant variation of quantitative SLP values, even for an 
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identical MNP suspension. Further analysis of these results is still ongoing, and the 
publication of detailed results is expected in 2019/2020. 
 
2.3 The EURAMET project MagNaStand 
The EURAMET organisation has established the co-normative project MagNaStand, 
running from 2017 – 2020. The objective of MagNaStand is to collect the available 
knowledge on standardised measurements of MNPs, to create it where it is not readily 
available, to make this knowledge available for the standardisation of MNPs at ISO 
level, and to involve stakeholders from industry and academia. 
Specifically, this includes the preparation of standard operating procedures for static 
and dynamic magnetisation measurements and for specific loss power assessment in 
magnetic hyperthermia. The MagNaStand project works on the definition of long-term 
stability of MNP suspensions and of SLP in magnetic hyperthermia in a metrologically 
sound and traceable way.  
Another objective of the MagNaStand project is the preparation of future measure-
ment standards for MNP by summarizing the existing metrological knowledge in a 
structured form for static magnetic susceptibility, dynamic magnetic susceptibility and 
specific loss power in magnetic hyperthermia. 
The MagNaStand projects enables the continuous participation of European experts 
in the standardisation work at ISO/TC229. Thus, the scientific results of the pre-nor-
mative EU projects “NanoMag” and “RADIOMAG” can be introduced into the inter-
national standardisation process. This includes the definition of terms for magnetic 
quantities and the compartments of magnetic nanoparticles, actual versions of SOPs for 
magnetic measurements, and surveys of industrial requirements on standardisation of 
magnetic nanoparticles. MagNaStand experts are co-leaders of the development of 
ISO/TS 19807-2 “Magnetic beads for DNA extraction”, together with experts from 
China. 
3 Search of the EU CORDIS database for research projects 
that are relevant for MNP standardization 
In this chapter we present the evaluation of the Community Research and Development 
Information Service (CORDIS) database on research projects funded by the EU. The 
aim of this activity was to provide a short summary of the most important EU FP7 and 
H2020 projects on MNPs. The search terms are explained in Table 1. 
3.1 Results of the search of the CORDIS database 
The search of the CORDIS website was conducted using all search terms of Table 1 in 
quotation marks and connected by Boolean OR operators (i.e. “*magnetic *particle” 
OR “*magnetic *bead*” OR etc.).  
Afterwards the result was filtered by the homepage’s “Refine by:” option. Only re-
sults of the “Content Type: Project” which were part of “Programme: Horizon 2020” 
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or “Programme: FP7” were downloaded in tabular form as CSV-files and - for the full 
description of the project objectives – as PDF-booklets.  The search resulted in a total 
of 108 EU research projects with summarized project budgets of roughly € 267 million. 
In comparison, a search in the Research Portfolio Online Reporting Tools (RePORT) 
of the U.S. Department of Health & Human Services using the same search terms from 
Table 1 resulted in 214 projects with a total budget volume of $ 67 million. A close 
inspection of the search results revealed that despite the wide range of the search terms, 
a number of relevant EU projects concerned with MNPs that were already known to the 
authors were not captured. They were later added manually to the final list of relevant 
EU projects concerned with MNP. The final total number of EU projects concerned 
with MNP was 118 with a total budget of € 348 million. 
Table 1. Search terms in the CORDIS database for identification of relevant EU projects for 
MNP standardisation. 
Search term Description 
*magnetic *particle* Since the standardisation of magnetic nanoparticle char-
acteristics is our main goal, it is only natural to find all 
projects containing any variant form of “*magnetic *par-
ticle*” (e.g. “superparamagnetic nanoparticles”). 
*magnetic *bead* Some research groups use the notation “bead” instead of 
“particle”. Otherwise, the reason to use this search term 
is the same as “*magnetic *particle*”. 
iron oxide  
nanoparticle 
Iron oxide nanoparticles are by far the most commonly 
used magnetic nanoparticles. 
superparamagnetic* A salient feature of MNPs is their superparamagnetic be-
haviour. 
4 An online survey of researchers involved in MNP projects 
We compiled a list of contact addresses of the leaders of the identified EU MNP pro-
jects, enhanced by contacts from the NanoMag and RADIOMAG networks. Altogether, 
over 100 European researchers were asked to participate in an online survey on MNP 
standardisation.  We have received 32 responses, of which the most relevant results are 
summarized in this chapter in a question-answer scheme. 
4.1 Survey results 
Q. 01: Which of the following were your application areas of MNP? A. 01: 32 biomed-
ical applications, 14 MNP synthesis, 6 environmental applications, 9 pharmaceutical 
applications, 6 other. 
Q. 02: What was the Technology Readiness Level (TRL) of your MNP project? 
A. 02: 22% TRL1 – basic principles observed and reported, 19% TRL2 – technology 
concept and/or application formulated, 30% TRL3 – characteristic proof-of-concept, 
23% TRL4 –  component validation in lab environment, 2% TRL5 – component 
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validation in relevant environment, 2% TRL6 – prototype demonstration in relevant 
environment, 1% TRL7 – prototype demonstration in application environment, and 0 
in TRL8 – complete system in test and demonstration and TRL 9 – complete system in 
successful operation. 
Q. 03: What kinds of materials for MNP were used during the project? Please specify 
core- and coating material. A free-text answer was possible. A. 03: Magnetite (13) and 
maghemite (9) was the most common core material, other ferrites (Barium-Ferrite, 
Nickel-Ferrite, Nickel-Cobalt-Ferrite, etc.) (10) played also a role. The coating material 
came from these material groups:  
• Polymer/Organic which included plastics, polysaccharides and organic acids (53) 
• Metal/Alloy which included metals, metalloids and alloys (10) 
• Biofunctionalized which included bacteria and proteins (7) 
• No coating for uncoated MNPs (1) 
Q. 04: In which environment(s) were the MNP used? A. 04: 43% laboratory, 34% 
in-vitro (cell cultures), 25% in-vivo. 
Q. 05: Properties of the applied magnetic field: specify field strength and frequency 
during your MNP application. A 05.: see Fig. 2 
 
Fig. 2. Magnetic field strength and frequency during the MNP application. 
Q. 06: Did you use a static magnetic field or an alternating magnetic field? A.06: 25 
alternating magnetic field, 18 static magnetic field 
Q. 07: What are the sources of the MNP characteristics that you used, please rank. 
A. 07: Summary rank: 1. own measurements, 2. literature values 3. technical data sheet, 
4. custom measurement. 
Q. 08: Please rate the importance of proposed characteristics for your project 
(1=low, 5=high). A.08: see Fig. 3 
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Fig. 3. Importance of different MNP parameters. 
Q. 09: Please enter the approximate value range of the characteristics. A. 09: see 
Fig. 4 
 
Fig. 4. Mean value ranges for several MNP parameters (minimum, typical and maximum). 
Q. 10: Did you encounter any serious problems during the measurement process of 
important characteristic properties? A. 10: 64% no, 21% unclear measurement proce-
dure, 15% measurements were not reproducible. 
Q. 11: Are you aware of reference laboratories, where you could check or cross-
validate your own measurement results? A. 11: 50% yes, 37% no, 13% no answer. 
Q. 12: Please rank the most important measurement technique to characterize MNP. 
A. 12: 1. transmission electron microscopy (TEM), 2. magnetorelaxometry (MRX), 
3. Hysteresis loops (DC magnetometry), 4. ZFC/FC curves (temperature dependent DC 
magnetometry) and 5. X-ray powder diffraction (XRD). 
Q. 13: What are the most important characteristics? A. 13:  36 particle size, 27 sat-
uration magnetisation, 13 hydrodynamic size, 9 specific absorption rate, 8 stability of 
suspension, 8 chemical composition, 6 biological properties, 5 dispersity, all other <5. 
Q. 14: Did you use a standardized measurement protocol or were there any other 
standardisation aspects in your project? A. 14: 50% no, 25% yes, 25% no answer 
Q. 15: Did you encounter any problems with the used MNP due to erroneous/un-
specified characteristics? If yes, please elaborate. A. 15: People were dissatisfied with 
numerous things involving erroneous or unspecified characteristics of MNPs. Most of 
the complaints can be summarized by stating that the information provided by manu-
facturers was incomplete. Complaints involved missing expiration dates, wrong or 
missing concentration values, wrong or missing magnetite/maghemite indications, un-
known surface compositions, stability change over time and recommended storage 
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conditions. Several participants also described problems reproducing previously ob-
tained or published results. 
Q. 16: How would you rate the current state of standardization of MNP? (1=low, 
4=high). A. 16: see Fig. 5. 
 
Fig. 5. Rating of current standardisation of different aspects of MNP handling. 
4.2 Discussion of the survey results 
The survey, although it is still based on a limited data base, shows clearly the wide 
range of applications and parameters that have to be considered when the standardisa-
tion of MNP is intended. It reveals that EU funded MNP research so far is restricted to 
very early or early Technology Readiness Levels. This might be one reason that the 
need for standardisation has been underestimated so far. On the other hand, the survey 
demonstrates that even in early research in scientific labs people often encounter prob-
lems with non-standardised parameters and procedures and non-reproducible measure-
ment results. The need for further standardisation is clearly demonstrated. The survey 
gives valuable hints, which measurement methods and parameters are most important 
and would most benefit from standardised procedures. 
5 Summary 
Despite the huge economic importance of magnetic nanoparticles, there exists no stand-
ardised description and measurement of their basic magnetic properties. This is espe-
cially surprising with respect to the 118 research projects and the budget of € 348 mil-
lion that the European Union has invested into MNP related projects since the FP7 
program. The pre- and co-normative EU projects NanoMag, RADIOMAG and 
MagNaStand have made decisive steps to change this situation. Currently, Europe is an 
important contributor to the standardisation of magnetic nanomaterials that is per-
formed in the ISO/TC229 “Nanotechnologies” committee. The efforts for harmonisa-
tion are based on surveys and other interactions with academic and industrial stake-
holders.  
We have presented the detailed content of such a survey in order to stimulate a dis-
cussion on the most urgent needs in MNP metrology. In addition to the basic description 
that is currently developed at ISO, standard operating procedures for magnetic meas-
urements, calibrated measurement devices and certified reference materials for mag-
netic MNP properties are desirable outcomes of future research. 
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